2,162
Views
18
CrossRef citations to date
0
Altmetric
Editorial

Prospects for safe and effective vaccines against prion diseases

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Mohammad Farooque Hassan, Sher Hayat Khan, Masroor Ellahi Babar, Lifeng Yang, Tariq Ali, Jamal Muhammad Khan, Syed Zahid Ali Shah, Xiangmei Zhou, Tanveer Hussain, Ting Zhu, Tariq Hussain & Deming Zhao. (2016) Polymorphism analysis of prion protein gene in 11 Pakistani goat breeds. Prion 10:4, pages 290-304.
Read now
Jesús R. Requena, Krister Kristensson, Carsten Korth, Chiara Zurzolo, Marion Simmons, Patricia Aguilar-Calvo, Adriano Aguzzi, Olivier Andreoletti, Sylvie L. Benestad, Reinhard Böhm, Karen Brown, Byron Calgua, José Antonio del Río, Juan Carlos Espinosa, Rosina Girones, Sue Godsave, Ludwig E. Hoelzle, Michael R. Knittler, Franziska Kuhn, Giuseppe Legname, Paul Laeven, Neil Mabbott, Eva Mitrova, Andreas Müller-Schiffmann, Mario Nuvolone, Peter J. Peters, Alex Raeber, Klaus Roth, Matthias Schmitz, Björn Schroeder, Tiziana Sonati, Lothar Stitz, Albert Taraboulos, Juan María Torres, Zheng-Xin Yan & Inga Zerr. (2016) The Priority position paper: Protecting Europe's food chain from prions. Prion 10:3, pages 165-181.
Read now

Articles from other publishers (16)

Scott Napper & Hermann M. Schatzl. (2023) Vaccines for prion diseases: a realistic goal?. Cell and Tissue Research 392:1, pages 367-392.
Crossref
Hermann Unger, Richard T. Kangethe, Fatima Liaqat & Gerrit J. Viljoen. (2022) Advances in Irradiated Livestock Vaccine Research and Production Addressing the Unmet Needs for Farmers and Veterinary Services in FAO/IAEA Member States. Frontiers in Immunology 13.
Crossref
Neil A. Mabbott, Barry M. Bradford, Reiss Pal, Rachel Young & David S. Donaldson. (2020) The Effects of Immune System Modulation on Prion Disease Susceptibility and Pathogenesis. International Journal of Molecular Sciences 21:19, pages 7299.
Crossref
Yue Ma & Jiyan Ma. (2020) Immunotherapy against Prion Disease. Pathogens 9:3, pages 216.
Crossref
Syed Beenish Rufai, Ayush Gupta & Sarman Singh. 2019. Pathogenicity and Drug Resistance of Human Pathogens. Pathogenicity and Drug Resistance of Human Pathogens 283 302 .
Thomas Wisniewski & Fernando Goñi. 2018. Human Prion Diseases. Human Prion Diseases 419 430 .
Neil A. Mabbott, James D. Alibhai & Jean Manson. 2018. Human Prion Diseases. Human Prion Diseases 85 107 .
Neil Mabbott. (2017) How do PrPSc Prions Spread between Host Species, and within Hosts?. Pathogens 6:4, pages 60.
Crossref
Ken S. Rosenthal & Daniel H. Zimmerman. (2017) J-LEAPS vaccines elicit antigen specific Th1 responses by promoting maturation of type 1 dendritic cells (DC1). AIMS Allergy and Immunology 1:2, pages 89-100.
Crossref
Chaoxi Wu, Xiaoying Wang, Jianjing Wang, Zhen Zhang, Zhiping Wang, Yifei Wang & Shunqing Tang. (2017) Tile-based self-assembly of a triple-helical polysaccharide into cell wall-like mesoporous nanocapsules. Nanoscale 9:28, pages 9938-9945.
Crossref
Kenta Teruya, Ayumi Oguma, Keiko Nishizawa, Maki Kawata, Yuji Sakasegawa, Hiroshi Kamitakahara & Katsumi Doh-ura. (2016) A Single Subcutaneous Injection of Cellulose Ethers Administered Long before Infection Confers Sustained Protection against Prion Diseases in Rodents. PLOS Pathogens 12:12, pages e1006045.
Crossref
Neil A. Mabbott. 2016. Encyclopedia of Immunobiology. Encyclopedia of Immunobiology 184 199 .
Sergio Rosales-MendozaSergio Rosales-Mendoza. 2016. Algae-Based Biopharmaceuticals. Algae-Based Biopharmaceuticals 65 75 .
Siddhartha Mahanty, Antoine Prigent & Olivier Garraud. (2015) Immunogenicity of infectious pathogens and vaccine antigens. BMC Immunology 16:1.
Crossref
Gabriel B. Pinto, Jorge Espinoza, Selene Juliá, Javier Blanco Viera & Pedro M. Aponte. (2015) ENCEFALOPATÍA ESPONGIFORME BOVINA Y SU DIAGNÓSTICO: REVISIÓN. ECUADOR ES CALIDAD: Revista Científica Ecuatoriana 2:2.
Crossref
Neil Andrew Mabbott & Barry Matthew Bradford. (2015) The Good, the Bad, and the Ugly of Dendritic Cells during Prion Disease. Journal of Immunology Research 2015, pages 1-13.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.